OTR-AC (Ostarine O-Acetate) Powder
|OTR-AC / Ostarine-O-Acetate|
|Molar Mass||431.37 g/mol|
|IUPAC Name||5-(1H-pyrazol-5-yl)-1-[2-[4-(trifluoromethoxy)phenoxy]ethyl]indole-2-carboxylic acid|
OTR-AC Powder is an innovative research product developed exclusively for scientific exploration, emphasizing its application in research and refraining from any mention of human consumption. This compound serves as a valuable tool for researchers investigating its unique properties and potential benefits in various research domains.
OTR-AC, a derivative of Ostarine O-Acetate, belongs to the class of selective androgen receptor modulators (SARMs). Recognized for its potential impact on androgen receptors, it has become a focus of research due to its potential influence on muscle tissue and bone health.
OTR-AC Powder finds versatile applications in research domains, offering researchers a tool to explore its potential benefits. Its applications extend to investigations into lean body mass, postmenopausal osteoporosis, and the improvement of muscle tissue.
OTR-AC on Lean Body Mass
Studies suggest that OTR-AC may have potential applications in preserving or increasing lean body mass. Research in this domain aims to understand its mechanisms of action and potential therapeutic applications in conditions related to muscle wasting.
OTR-AC on Postmenopausal Osteoporosis
Preliminary research indicates that OTR-AC may have implications for postmenopausal osteoporosis, potentially influencing bone density. Investigations into its effects on bone health contribute to understanding its potential applications in osteoporotic conditions.
OTR-AC on Improvement of Muscle Tissue
Research suggests that OTR-AC may have potential benefits in enhancing muscle tissue. Studies exploring its impact on muscle growth and regeneration contribute to understanding its potential applications in supporting muscle health.
OTR-AC (Ostarine O-Acetate) Powder, developed exclusively for research purposes, provides researchers with a unique avenue for investigating its potential benefits in lean body mass, postmenopausal osteoporosis, and the improvement of muscle tissue. The distinctive characteristics of OTR-AC make it a promising subject for further exploration in musculoskeletal and metabolic research.
- Dalton JT, Barnette KG, Bohl CE, Hancock ML, Rodriguez D, Dodson ST, Morton RA, Steiner MS. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. J Cachexia Sarcopenia Muscle. 2011 Sep;2(3):153-161. doi: 10.1007/s13539-011-0034-6. Epub 2011 Aug 2. PMID: 22031847; PMCID: PMC3177038. [Read More].
- Leciejewska, N.; Kołodziejski, P.A.; Sassek, M.; Nogowski, L.; Małek, E.; Pruszyńska-Oszmałek, E. Ostarine-Induced Myogenic Differentiation in C2C12, L6, and Rat Muscles. Int. J. Mol. Sci. 2022, 23, 4404. https://doi.org/10.3390/ijms23084404. [Read More].
- Hoffmann, D.B., Komrakova, M., Pflug, S. et al. Evaluation of ostarine as a selective androgen receptor modulator in a rat model of postmenopausal osteoporosis. J Bone Miner Metab 37, 243–255 (2019). https://doi.org/10.1007/s00774-018-0929-9 [Read More].